Construction of an inducible nitric-oxide synthase gene transferring vector mediated by retrovirus

Acta Pharmacologica Sinica

Volumn 19, Issue 2, 1998, Pages 121-127

  Zang, Meng Wei ^a   Peng, Xue Xian ^b   Hu, Ping ^a   Liu, Jing Sheng ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

Complementary DNA; Eukaryotic cells; Gene expression regulation; Genetic vectors; Nitric oxide synthase; Polymerase chain reaction; Recombinant DNA; Restriction mapping; Retroviridae

Indexed keywords

COMPLEMENTARY DNA; NITRIC OXIDE SYNTHASE; VIRUS VECTOR;

ARTICLE; CYTOMEGALOVIRUS; DNA SEQUENCE; ENZYME INDUCTION; EUKARYOTIC CELL; GENE EXPRESSION REGULATION; GENE TRANSFER; NEUROTRANSMITTER RELEASE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION MAPPING; RETROVIRUS; VIRUS EXPRESSION;

CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; RETROVIRIDAE;

EID: 2642677646     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Xu W, Charles IG, Liu L, Moncada S, Emson P. Molecular cloning and structural organization of the human inducible nitric oxide synthase gene (NOS2). Biochem Biophys Res Commun 1996; 219: 784-8.
2. Adachi H, Iida S, Oguchi S, Ohshima H, Suzuki H, Nagasaki K, et al. Molecular cloning of a cDNA encoding an inducible calmodulin-dependent nitric-oxide synthase from rat liver and its expression in COS1 cells. Eur J Biochem 1993; 217: 37-43.
3. Zang MW, Fang F, Liu JS. NO-cGMP signal transduction system. Basic Med Sci Clin 1996; 16: 408-19.
4. Wang Z, Bilsky EJ, Porreca F, Sadee W. Constitutive μ opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci 1994; 54: PL339-50.
5. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa-opioids. Pain 1994; 56: 69-75.
6. Cappendijk SLT, de Vries R, Dzoljic MR. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci Lett 1993; 162: 97 -100.
7. Babey AM, Kolesnikov Y, Cheng J, Inturrisi CE, Trifilletti RR, Pasternak GW. Nitric oxide and opioid tolerance. Neuropharmacology 1994; 33: 1463-70.
8. Liu ZQ, Qiang WN, Zhang F, Zang MW, Liu JS. The expression of rat brain constitutive nitric oxide synthase in NG108-15 cell. Acta Acad Med Sin 1997; 19: 11-7.
9. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 1992; 89: 6711-5.
10. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.
11. Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993; 217: 581-99.
12. Kozak M. An analysis of 5-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1967; 15: 8125-46.
13. Wu C, Thang J, Abu-Soud H, Ghosh DK, Stuehr DJ. High-level expression of mouse inducible nitric oxide synthase in Escherichia coli requires coexpression with calmodulin. Biochem Biophys Res Commun 1996; 222: 439-44.
14. Fossetta JD, Niu XD, Lunn CA, Zavodny PJ, Narula SK, Lundell D. Expression of human inducible nitric oxide synthase in Escherichia coli. FEBS Lett 1996; 379: 135-8.
15. Moss DW, Wei X, Liew FY, Moncada S, Charles IG. Enzymatic characterization of recombinant murine inducible nitric oxide synthase. Eur J Pharmacol 1995; 289: 41-8.